GLP-1, or {glucagon-like|glucagon like|glucagon) peptide-1, is currently emerging as a significant focus in healthcare research, largely due to its remarkable impact on controlling ailments such as adult-onset diabetes and obesity. New studies have revealed that in addition to glucose management, GLP-1 medications offer promise for cardiovascular h